Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastat
(Q38473855)
scientific article published on March 2009
scientific article published on March 2009
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||
| (P50) |
(Q106623018)
(Q40222582)
|
||||||||||||||||||||
| (P304) |
931-935
|
||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||
| (P433) |
11
|
||||||||||||||||||||
| (P478) |
53
|
||||||||||||||||||||
| (P577) |
Sunday, March 1, 2009
|
||||||||||||||||||||
| (P921) |
(Q75298271)
(Q28350)
|
||||||||||||||||||||
| (P1433) |
(Q2984355)
|
||||||||||||||||||||
| (P1476) |
"Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastat" (language: en)
|